Status:

RECRUITING

Radial Vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complication Reduction in Cardiac Catheterization (REBIRTH)

Lead Sponsor:

Minneapolis Heart Institute Foundation

Conditions:

Patient Satisfaction

Vascular Access Complication

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This is a phase IV, prospective, open label, randomized-controlled study that will compare radial access with state-of-the-art femoral access in patients without ST-segment elevation acute myocardial ...

Eligibility Criteria

Inclusion

  • Age 18 years and older
  • Undergoing diagnostic angiography for ischemic symptoms with possible PCI, or undergoing planned urgent or elective PCI
  • Has provided informed consent and agrees to participate
  • Patients must be equally eligible to undergo cardiac catheterization via radial or femoral access

Exclusion

  • Primary PCI for STEMI
  • Planned right heart catheterization
  • Valvular heart disease requiring valve surgery within 30 days after the index procedure
  • Hemodialysis access (arteriovenous fistula or graft) in the arm to be used for PCI in case of assignment to radial approach (the opposite arm may be used for radial access if a dialysis graft is present in one)
  • Peripheral arterial disease prohibiting vascular access
  • Presence of bilateral internal mammary artery coronary bypass grafts
  • International normalized ratio ≥1.5 while treated with oral vitamin K antagonists (i.e. warfarin) Receipt of oral factor Xa or IIa inhibitors ≤24 h before procedure
  • Planned staged PCI within 30 days after index procedure.
  • Any planned surgeries within 30 days after index procedure
  • Planned dual arterial access (for example for chronic total occlusion PCI)
  • Coexisting conditions that limit life expectancy to less than 30 days
  • Positive pregnancy test

Key Trial Info

Start Date :

November 15 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 19 2028

Estimated Enrollment :

3266 Patients enrolled

Trial Details

Trial ID

NCT04077762

Start Date

November 15 2019

End Date

August 19 2028

Last Update

January 24 2025

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

San Francisco VA Medical Center

San Francisco, California, United States, 94121

2

Mayo Clinic Florida

Jacksonville, Florida, United States, 32224

3

Joseph Maxwell Cleland Atlanta VA Medical Center

Decatur, Georgia, United States, 30033

4

Henry Ford Hospital

Detroit, Michigan, United States, 48202